RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,716,000 | -34.5% | 35,743 | -36.0% | 0.08% | -21.2% |
| Q4 2019 | $2,620,000 | +98.5% | 55,829 | 0.0% | 0.10% | +70.7% |
| Q3 2019 | $1,320,000 | +128.8% | 55,829 | +190.9% | 0.06% | +141.7% |
| Q2 2019 | $577,000 | -73.6% | 19,190 | -91.3% | 0.02% | -71.1% |
| Q2 2018 | $2,189,000 | +21.7% | 219,952 | -35.0% | 0.08% | +18.6% |
| Q1 2018 | $1,798,000 | -40.6% | 338,565 | -5.0% | 0.07% | -40.2% |
| Q4 2017 | $3,028,000 | -47.6% | 356,237 | -10.0% | 0.12% | -43.5% |
| Q3 2017 | $5,779,000 | -22.1% | 395,818 | 0.0% | 0.21% | -24.7% |
| Q2 2017 | $7,418,000 | – | 395,818 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daiwa Securities Group Inc. | 266 | $32,000 | 0.00% |